Full-length in meso structure and mechanism of rat kynurenine 3-monooxygenase inhibition
Mimasu et al. report a rat full-length structure of kynurenine 3-monooxygenase (KMO) in its membrane-embedded form, complexed with two inhibitors. They find that the dimeric interface of KMO is critical for its activity. This study provides insights into the drug development strategies that target K...
Guardado en:
Autores principales: | Shinya Mimasu, Hiroaki Yamagishi, Satoshi Kubo, Mie Kiyohara, Toshihiro Matsuda, Toshiko Yahata, Heather A. Thomson, Christopher D. Hupp, Julie Liu, Takao Okuda, Kenichi Kakefuda |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6e58b6005eed4d88a8484826be69489a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase
por: Jonathan P. Hutchinson, et al.
Publicado: (2017) -
Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington’s disease
por: Marie Katrin Bondulich, et al.
Publicado: (2021) -
Kynurenine and depressive symptoms in a poststroke population
por: Bensimon K, et al.
Publicado: (2014) -
Electrochemical Determination of Kynurenine Pathway Metabolites—Challenges and Perspectives
por: Ilona Sadok, et al.
Publicado: (2021) -
Serum profiles of tryptophan-kynurenine pathway metabolites in psoriasis
por: Mariko Seishima, et al.
Publicado: (2021)